Ishare Nasdaq Biotech ETF (NASDAQ:IBB) shares traded on -1.7% below secure line and closed at $111.9. The stock exchanged hands 4.25 Million shares versus average trading capacity of 2.22 Million shares. It has a market cap of $0.

Investors as well as the sell-side will be paying close attention to how the actual numbers compare with the estimates. Earnings surprises can have a huge impact on a company’s stock price. Several studies suggest that positive earnings surprises not only lead to an immediate hike in a stock’s price, but also to a gradual increase over time. Hence, it’s not surprising that some companies are known for routinely beating earning projections. A negative earnings surprise will usually result in a decline in share price.

On the other hand Ishare Nasdaq Biotech ETF (NASDAQ:IBB) has Relative Strength Index (RSI 14) of 49.98 along with Average True Range (ATR 14) of 1.94. Where the relative strength index (RSI) is a technical momentum indicator that compares the magnitude of recent gains to recent losses in an attempt to determine excess buying & selling conditions of an asset, it is one of the most popular technical indicators, computed on the basis of the speed and direction of a stock’s price movement. The RSI value will always move between 0 and 100; the value will be 0 if the stock falls on all 14 days, and 100, if the price moves up on all the days) as suggested by J Welles Wilder. In terms of market analysis and trading signals, RSI moving above the horizontal 30 reference level is viewed as a bullish indicator, while the RSI moving below the horizontal 70 reference level is seen to be a bearish indicator. The level of 50 represents neutral market momentum and corresponds with the center line in other oscillators such as MACD (Moving Average Convergence/Divergence). The average true range (ATR) is a measure of volatility introduced by Welles Wilder.

Consequently Ishare Nasdaq Biotech ETF (NASDAQ:IBB)’s weekly and monthly volatility is 1.60%, 1.57% respectively.